Strides Pharma Science Limited (STAR.NS)

975.00 +33.25 (+3.53%) At close: 03:30PM IST

Strides Pharma Science Limited

Strides House
Bilekahalli Bannerghatta Road
Bengaluru 560076
India
91 80 6784 0000
https://www.strides.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Arun Kumar Pillai B.Com.	Founder & Executive Chairperson	60M	N/A	1961
Mr. Badree Komandur	MD & Group CEO	44M	N/A	1972
Ms. Manjula Ramamurthy	Compliance Officer & Company Secretary	N/A	N/A	N/A
Mr. Vikesh Kumar	Group CFO & Chief Investor Relations Officer	N/A	N/A	1985
Mr. P. V. S. Ramaraju	Chief Operating Officer	N/A	N/A	N/A
Sormistha Ghosh	Group General Counsel & Chief Risk Officer	N/A	N/A	N/A
Ms. Surabhi Loshali	Group Chief Human Resource Officer	N/A	N/A	1980
Mr. C. K. Sundar	Executive Vice President of Operations	N/A	N/A	N/A
Mr. Kevin P. Cook	Senior Vice President of Strides Pharma Inc.	N/A	N/A	N/A
Mr. Umesh Kale	Chief Quality Officer	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company has a strategic partnership with Orbicular Pharmaceutical Technologies Private Limited to develop, manufacture, and commercialize nasal sprays. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.

Corporate governance

Strides Pharma Science Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.